Clinical Trial Update: Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2) [Phase 1, Phase 2]

View source ↗

Summary

An early-phase clinical trial (iSPASM-2) is evaluating induced suppression of platelet activity in patients with aneurysmal subarachnoid hemorrhage. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Snippet

Sponsor: Dr David Hasan, M.D. | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING